Autoimmune hemolytic anemia associated with postirradiation malignant stromal tumor (leiomyosarcoma) of the jejunum.
We describe a patient who presented with autoimmune hemolytic anemia and small bowel obstruction secondary to a malignant stromal tumor (leiomyosarcoma) of the jejunum, 25 years postchemotherapy and radiation treatment for stage IIA Hodgkin's disease. The patient was treated with corticosteroid therapy and surgical resection of the jejunal tumor. We conclude that autoimmune hemolytic anemia may be an unusual presentation for postirradiation sarcoma.
Lee
K H
KH
Harvard School of Medicine, Partners Neurology Program, Brigham and Women's Hospital, Boston, USA.
Fiedler
P
P
Passarelli
J
J
Bobrow
S
S
D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology* / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology*; D007580:Jejunal Neoplasms / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D007890:Leiomyosarcoma / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects
D011241:Prednisone